Roundtable: Top Biomedical Test Equipment Trends
Here, four experts in the biomedical test equipment industry share insights on the current trends and strategies advancing the sector.
Here, four experts in the biomedical test equipment industry share insights on the current trends and strategies advancing the sector.
Rigel Medical’s new, portable UniPulse 400 defibrillator analyzer offers rapid and...
Here, four individuals with a vested stake in the biomedical test equipment market sit down with 24x7 Magazine to discuss what’s new in test equipment and what purchasers should know before signing on the dotted line.
Here, four experts in the biomedical test equipment industry share insights on the current trends and strategies advancing the sector.
St. Charles, Mo.-based BC Biomedical announces that its IPA-3400 Infusion Pump Analyzer is now patented under U.S. Patent No. 10,100,828. The IPA-3400 provides continuous monitoring of fluid flow without the need to stop and perform intermittent drains like older technologies do.
Read MoreDesigned to make comprehensive patient monitor testing quick and easy, the ProSim 8 tests eight vital sign parameters that are synchronized with one another, just as in the human body.
Read MoreTo say that 2018 marks a monumental year for BC Group International would be a vast understatement: The St. Charles, Mo.-based company—which distinguishes itself as a leading provider of biomedical test equipment and measurement equipment for the global medical device technical services marketplace—celebrates 30 years in operation this year.
Read MoreIn this article, Greg Alkire, vice president of sales and marketing at Sun Valley, Calif.-based Pronk Technologies, sits down with 24×7 Magazine to discuss how innovation—and a little out-of-the-box thinking—led to the creation of Pronk and why HTM professionals are now being tasked with more responsibilities than ever before.
Read MoreThe global medical device testing services market is expected to reach $13.4 billion by 2025, expanding at a CAGR of 11.5% during the forecast period, according to a new study. Increasing spending in the preclinical phase of medical devices, coupled with the growing outsourcing rate, is anticipated to help the market gain significant traction.
Read MoreIt’s one of the biggest challenges biomeds face: The relentless need for medical device testing—for ensuring that everything is working as intended in order to guarantee the highest standards of patient care. With that in mind, we reached out to three biomedical test product companies and asked them about their latest innovations and how they might help HTM teams do their jobs. Here’s what they told us.
Read MoreAccording to a new report by MarketsandMarkets, the global medical device testing market is projected to surge from its current $8.56 billion valuation to $12.26 billion by 2023, growing at a compound annual growth rate of 6.18%.